Newswire STAT+ Reveals EPIC Investigation and Unanticipated Developments from Teladoc October 31, 2026 STAT has announced its participation in the HLTH conference in Las Vegas on November 18,…
Newswire ICH Adopts New M15 Guideline for Model-Informed Drug Development October 31, 2026 Adopted by the International Council for Harmonisation (ICH) in February 2026, the new ICH M15…
Newswire Genmab Soars to Record Highs After Cancer Drug Succeeds in Key Trial October 31, 2026 Genmab’s market capitalization surged by over $7 billion following positive trial results for a recently-acquired…
Newswire RFK Jr backs compounding of six unapproved peptides in new policy October 31, 2026 In a significant move for the pharmaceutical compounding sector, Robert F. Kennedy Jr. has endorsed…
Newswire Gaelic Labs: the EU Critical Medicines Act will have a positive impact on supply October 31, 2026 Gaelic Labs anticipates significant advantages stemming from the EU’s Critical Medicines Act, which aims to…
Newswire HHS to Allow Compounders to Make 6 Unapproved Peptides October 31, 2026 The U.S. Department of Health and Human Services (HHS) has announced that it will not…
Newswire IDWeek 2026: Abrysvo Data in Nursing Home Residents Could Support Re-vaccination October 31, 2026 Abrysvo, a respiratory syncytial virus (RSV) vaccine, was first approved in the United States in…
Newswire FDA Issues Guidance on Essential Drug Delivery Performance Characteristics for Devices October 31, 2026 The FDA has released new guidance aimed at enhancing the development of stand-alone devices and…
Newswire Kennedy’s Rally Highlights Growing Opposition to Vaccines and Big Agriculture Ahead of 2026 Midterms October 30, 2026 On Wednesday night in Clive, Iowa, a gathering of Make America Healthy Again activists and…
Newswire AAV Gene Therapies Demand New Strategies for Sustainable Development October 30, 2026 Adeno-associated virus (AAV) gene therapies have transformed the treatment landscape for rare and genetic diseases,…